Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging.

"Financial/nonfinancial disclosures: The authors have reported to CHEST the following: Raúl San José Estépar. reports grants from the 10.13039/100000002National Institutes of Health, 10.13039/100000050National Heart, Lung, and Blood Institute, during the conduct of the study; personal fees from Leuko Labs; grants and personal fees from Boehringer Ingelheim; and personal fees from 10.13039/100007560Chiesi USA Inc. G. R. W. reports grants from the National Institutes of Health; grants and other from Boehringer Ingelheim and Janssen Pharmaceuticals; other from Quantitative Imaging Solutions and PulmonX; other from 10.13039/100004330GlaxoSmithKline, 10.13039/100004336Novartis, Vertex, and CSL Behring, outside the submitted work; and his spouse works for Biogen. Raúl San José Estépar and G. R. W. are also founders and co-owners of Quantitative Imaging Solutions, which is a company that provides image-based consulting and develops software to enable data-sharing. None declared (F. N. R., P. D., E. H., I. S., G. V. S.-F., J. C. R., R. S. J. E., S. Y. A., A. R. H., B. A. M., J. A. L., A. B. W.)."

"FUNDING/SUPPORT: This study was supported in part by 10.13039/100000050National Heart, Lung, and Blood Institute Grants [1K23HL136905, F. N. R; 5R01HL116473, Raúl San José Estépar and G. R. W.; 1R01HL149877, Raúl San José Estépar; and 5K08HL145118, S. Y. A.]."